The glucagon-like peptide-1 (GLP-1) drugs poised to conquer obesity

被引：0
|
作者：
Yin, Jun [1 ]
Liu, Yuexing [1 ]
Jia, Weiping [1 ,2 ]
机构：
[1] Department of Endocrinology and Metabolism, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiaotong University, School of Medicine, Shanghai,200233, China
[2] Institute for Proactive Healthcare, Shanghai Jiao Tong University, Shanghai,200030, China
来源：
Chinese Science Bulletin | 2024年 / 69卷 / 35期
关键词：
D O I：
10.1360/TB-2024-0417
中图分类号：
学科分类号：
摘要：
43
引用
收藏
页码：5094 / 5099
相关论文
共 50 条
  • [21] STRUCTURE OF HUMAN GLP-1(GLUCAGON-LIKE PEPTIDE-1) CONTAINING PEPTIDES
    ORSKOV, C
    KOFOD, H
    RABENHOJ, L
    WETTERGREN, A
    HOLST, JJ
    DIABETOLOGIA, 1992, 35 : A109 - A109
  • [22] Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology
    D. J. Drucker
    C. F. Rosen
    Diabetologia, 2011, 54 : 2741 - 2744
  • [23] Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology
    Drucker, D. J.
    Rosen, C. F.
    DIABETOLOGIA, 2011, 54 (11) : 2741 - 2744
  • [24] Glucagon-like peptide 1 (GLP-1) and eating
    Gutzwiller, JP
    Degen, L
    Heuss, L
    Beglinger, C
    PHYSIOLOGY & BEHAVIOR, 2004, 82 (01) : 17 - 19
  • [25] The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis
    Li, Ya-Kun
    Ma, Dong-Xia
    Wang, Zhi-Min
    Hu, Xiao-Fan
    Li, Shang-Lin
    Tian, Hong-Zhe
    Wang, Meng-Jun
    Shu, Yan-Wen
    Yang, Jun
    PHARMACOLOGICAL RESEARCH, 2018, 131 : 102 - 111
  • [26] Somatostatin is a major, paracrine regulator of glucagon-like peptide-1 (GLP-1) secretion
    Hansen, L
    Mineo, H
    Bisgaard, T
    Jorgensen, PN
    Holst, JJ
    DIABETOLOGIA, 1997, 40 : 498 - 498
  • [27] Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
    Abba J. Kastin
    Victoria Akerstrom
    Weihong Pan
    Journal of Molecular Neuroscience, 2002, 18 : 7 - 14
  • [28] Can glucagon-like peptide-1(GLP-1) analogues make neuroprotection a reality?
    Maryna V.Basalay
    Sean M.Davidson
    Derek M.Yellon
    Neural Regeneration Research, 2020, 15 (10) : 1852 - 1853
  • [29] Glucagon-like peptide-1 (GLP-1) action in the mouse area postrema neurons
    Kawatani, Masahiro
    Yamada, Yuichiro
    Kawatani, Masahito
    PEPTIDES, 2018, 107 : 68 - 74
  • [30] Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
    Unger J.R.
    Parkin C.G.
    Diabetes Therapy, 2011, 2 (1) : 29 - 39
12345